GOLDMAN SACHS GROUP INC - VIRACTA THERAPEUTICS INC ownership

VIRACTA THERAPEUTICS INC's ticker is VIRX and the CUSIP is 92765F108. A total of 50 filers reported holding VIRACTA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.67 and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of VIRACTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$502,000
-36.6%
117,493
-42.5%
0.00%
Q2 2022$792,000
+10.5%
204,164
+35.5%
0.00%
Q1 2022$717,000
+2.1%
150,689
-21.6%
0.00%
Q4 2021$702,000
-48.9%
192,251
+12.3%
0.00%
Q3 2021$1,373,000
-53.7%
171,194
-34.5%
0.00%
-100.0%
Q2 2021$2,966,000
-46.9%
261,513
-56.7%
0.00%0.0%
Q1 2021$5,587,000603,9740.00%
Other shareholders
VIRACTA THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Aisling Capital Management LP 288,571$421,3140.28%
BVF INC/IL 3,614,662$5,277,4070.22%
Samsara BioCapital, LLC 689,709$1,006,9750.22%
Rubric Capital Management LP 1,330,983$1,943,2350.08%
HAMILTON LANE ADVISORS LLC 35,791$520.02%
MAI Capital Management 426,916$623,2970.01%
Jasper Ridge Partners, L.P. 92,939$135,6910.01%
BOURGEON CAPITAL MANAGEMENT LLC 17,500$25,5500.01%
RP Management, LLC 3,700$5,4020.01%
Laurion Capital Management LP 698,000$1,019,0800.01%
View complete list of VIRACTA THERAPEUTICS INC shareholders